In a filing, Hims & Hers Health Inc revealed its Chief Commercial Officer Chi Michael unloaded Company’s shares for reported $1.77 million on Jul 31 ’25. In the deal valued at $67.00 per share,26,350 shares were sold. As a result of this transaction, Chi Michael now holds 278,654 shares worth roughly $17.65 million.
Then, Chi Michael sold 250 shares, generating $16,110 in total proceeds. Upon selling the shares at $64.44, the Chief Commercial Officer now owns 278,654 shares.
Before that, Chi Michael bought 250 shares. Hims & Hers Health Inc shares valued at $16,110 were divested by the Officer at a price of $64.44 per share.
Needham downgraded its Hims & Hers Health Inc [HIMS] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Needham’s analysts, who remained covering the stock and in early June has reiterated a ‘”a Buy”‘ rating for it. TD Cowen also remained covering HIMS and has decreased its forecast on April 29, 2025 with a “Hold” recommendation from previously “Buy” rating. Morgan Stanley revised its rating on February 18, 2025. It rated HIMS as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of HIMS
On Monday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock jump 1.28% to $63.35. Over the last five days, the stock has gained 7.96%. Hims & Hers Health Inc shares have risen nearly 198.26% since the year began. Nevertheless, the stocks have risen 161.99% over the past one year.
How much short interest is there in Hims & Hers Health Inc?
A steep rise in short interest was recorded in Hims & Hers Health Inc stocks on 2025-07-15, growing by 3.6 million shares to a total of 65.3 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 61.69 million shares. There was a rise of 5.52%, which implies that there is a positive sentiment for the stock.
